guidelines

tirzepatide (mounjaro) for weight management: nice ta1026 eligibility + stopping rules

a practical ta1026 summary: who qualifies for tirzepatide within specialist weight management services, ethnicity-adjusted bmi thresholds, duration limits, and stopping rules, with pragmatic titration notes.

last reviewed: 2026-02-13

based on: NICE TA1026 (published 23 Dec 2024; last updated 01 Sep 2025)

reviewer: Dr Kola Tytler MBBS CertHE MBA MRCGP

view official NICE source

Common questions (GP-focused)

Transparency

This page is an educational, clinician-written summary of publicly available NICE guidance intended for trained healthcare professionals. It uses original wording (not copied text) and should be used alongside the full NICE source, local pathways, and clinical judgement. Doses provided are for general reference; always check the BNF/SPC.